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ABSTRACT
Pulp and oils (fruit extract) from Sea Buckthorn (Hippophae rhamnoides L. spp. Turkestanica) (HRL) seeds and berries have
been traditionally used in the treatment of different clinical and psychotic disorders and have significant implication in contemporary medicinal therapy. Schizophrenia is a chronic severe mental illness that affects approximately 1% of the population. Although
the first generation of antipsychotic drugs such as chlorpromazine and haloperidol are widely prescribed for the treatment of schizophrenia, their beneficial effects are accompanied by extrapyramidal side effects (EPS). The present study was designed to investigate the effects of oral supplementation of HRL fruit extract (HRL-FE) on behavioral deficits and changes in brain serotonin (5hydroxytryptamine; 5-HT) metabolism in rats administered with haloperidol repeatedly (two times a day at 09:00-09:30 A.M. and
05:00-05:30 P.M. at dose of 3.0 mg/kg body weight for two weeks. Results revealed that after two weeks of oral administration of
HRL-FE (4.0 mg/kg body weight), rats exhibited significant (p<0.01) increases in locomotor activity in home cages and exploratory
activity in open field arena. Repeated haloperidol treatment significantly (p<0.01) decreased brain tryptophan (TRP) and 5-HT and
these decreases were reversed by 4.0 mg/kg body weight HRL-FE. These data suggest that HRL-FE plays a modifying role against
the haloperidol induced behavioral deficits and could further extend as a nutritive therapy to conventional antipsychotic treatment in
schizophrenia.
Key words: sea buckthorn (Hippophae rhamnoides), haloperidol, locomotor activity, tryptophan, brain serotonin

INTRODUCTION
Medicinal uses of a magical plant Sea buckthorn
(Hippophae rhamnoides L. spp. turkestanica) (HRL) are
well documented in Asia and Europe (1-3). Modern medical science has made imposing progress in understanding
the role of dietary supplementations in the maintenance
of mental health and in the prevention of schizophrenia.
Increasing scientific evidence is available to support the
hypothesis that certain foods and food components have
beneficial physiological and psychological effects over
* Author for correspondence. Tel: +92-213-4511794;
Fax:+92-213-5377846;
E-mail: batool@uok.edu.pk; batool_fb@yahoo.com

and above the provision of basic nutrients. Many major
health problems (cancer, digestive problems, skin diseases, and cardiovascular symptoms etc.) are growing rapidly in the world especially in developing countries and
their therapy with synthetic compounds are cost-effective
and reported with side effects profile. Overwhelming
evidence from clinical trial data indicates that a plantbased diet can reduce the risk of various diseases (2).
Many traditional food products including fruits have
been found to contain components with potential health
benefits (3). Investigations on modern medicinal applications were initiated in Russia during the 1950s (3). Recently, the research focus has shifted more to the biologically active components in foods that have the potential to
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optimize mental well being and reduce risk of psychosis
and other diseases. The use of phytochemical or ingredients from Sea buckthorn or other medicinal plants is
a safe way for combating against these diseases. Different parts of Sea buckthorn have been used as traditional
therapies for diseases. The fruit, leaves, bark and seeds
of Sea buckthorn contain over 190 nutrients. Sea buckthorn is exceptionally rich in vitamin E with vitamins A,
C, D and K, etc(4). Its active ingredients include carotene,
flavonoids, phytosterols, serotonin, and eighteen amino
acids covering all eight essential amino acids, i.e., isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan (TRP) and valine (5). Later research has
shown that over long periods of time a ninth amino acid,
histidine, is also essential, as well as twenty-four mineral compounds including iron, zinc, calcium, magnesium, selenium, iodine, etc., that are important to good
health(4-5). Different preparations of Sea buckthorn in
the form of oils and pulp (fruit extract) are available and
recommended for various clinical, cosmetic and health
purposes(6). In spite of several usages of Sea buckthorn
plant, the most important and popular part are berries,
from which the juice is extracted. Research in the early
1960s has reported that 5-hydroxytryptamine (5-HT;
serotonin) is isolated from bark and pulp (fruit extract) of
HRL (7-8) while other studies have revealed that serotonin
has a prominent role in the treatment of mental disorder
like schizophrenia (9-10). Furthermore, it has been reported
that dietary manipulations of drug effects on the role of
brain serotonin are accountable to treat enigmatic disorder schizophrenia. Many neurotransmitter substances
are present in foods, and therefore, can directly influence
brain chemistry.
Motor-related side effects are commonly encountered in the treatment of schizophreniform psychoses
with so-called “classical” antipsychotic drugs such as
haloperidol that are known to block central dopamine
(DA) receptors with their DA-D2 antagonistic potential(1112)
. The ability of antipsychotic drugs to modulate serotonergic as well as dopaminergic function has been
suggested to be important for their efficacy and side-effect profile (13). However, it is also known that there are
interactions between dopaminergic and serotonergic
neurons in the central nervous system (CNS) which may
be of relevance to the extrapyramidal symptoms (EPS)
in rats (13). Serotonergic system is known to play a key
role in the modulation of the activity of dopaminergic
neurons. The nature of the modulation seems to be inhibitory. Thus lesions of the serotonergic cell bodies in the
raphe nuclei augmented apomorphine-induced locomotor behavior (11,13). There is also suggestive evidence from
early laboratory studies for important DA/5-HT interaction in the mediation of EPS functions, as displayed in
the catalepsy model in rats(14). In view of possible role
of serotonin, the aim of the present investigation was to
monitor the effects of oral administration of HRL-FE on
haloperidol induced behavioral deficits and changes in rat

brain 5-HT metabolism. The results suggest the contribution of serotonin and its precursor amino acid TRP as
adjuncts for the treatment of haloperidol induced EPS
symptoms and will also help in the development of nutraceuticals as a nutrient therapy in schizophrenia.

MATERIALS AND METHODS
I. Berries Collection and Fruit Extract Formulation
Sea buckthorn (Hippophae rhamnoides L. spp.
Turkestanica) (HRL) berries from Northern areas
(Hussainabad, Sakardu) of Pakistan were collected in the
first week of October when the plant grows wildly under
natural conditions. These berries were kept in plastic pots
and transported to University of Agriculture, Rawalakot,
Azad Kashmir. The fresh fruit were then cleaned and
pounded to pieces with a squeezer (15). The extract was
filtered and the filtrate was stored at -20°C in a refrigerator. The pulp was extracted manually by extracting seeds
from 50 berries of Sea buckthorn. The calculation was
done after weighing 100 berries and 100 sample seeds.
The crude extract was then diluted in sterile double-distilled water to make 40% HRL juice. To use 40% preparations of Sea buckthorn pulp, the calculations were done
by considering the wet seed weight as well. It was estimated that 50 berries of Sea buckthorn would yield pulp
weight of 4.0 g dissolved in 100 mL of water. This 4.0 g
of pulp did not include seeds weight. The juice solution
was administered orally via a feeding tube to groups of
rats for two weeks continuously at a dose of 4.0 mg/kg
body weight at an equivalent volume of 1.0 mL/kg body
weight in each group of rats in a balanced design.
II. Animals
Male Albino-Wistar rats with an average weight of
180 ± 20 g on arrival were purchased from Agha Khan
University (AKU) and group-housed (two rats per cage)
in an environmentally controlled room (ambient temperature 21 ± 1°C and relative humidity 55 ± 5%) on a 12:12
h light/dark cycle (lights on at 7:00 A.M.). A 5-day acclimatization period was allowed before animals were used
in experiments. After this period and 24 h before the
behavioral tests, the animals were individually housed
in an environmentally controlled test room in transparent Perspex cages (dimensions 26×26×26 cm, W×L×H).
Food (standard rat diet) and tap water were continuously
available to animals during experiment. The rats used
for the treatment were all experimentally naive animals.
All experimental protocols were approved and performed
in strict accordance with the Guide for the Care and Use
of Laboratory Animals (Institute of Laboratory Animal
Resources on Life Sciences, US National Research Council, 1996) and the institutional Ethical Committee’s
guidelines for animal research.
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III. Drugs and Injections
Haloperidol (Serenace; manufactured under license
from G.D. Searle and Co. U.S.A, by Searle Pakistan Ltd.
Laboratories) was available in 5.0 mg/mL ampoules
(injectable solution) diluted to desired dose (3.0 mg/
kg body weights) in saline solution (0.9% NaCl). Injections were given twice daily between 09:00-09:30 A.M.
and 05:00-05:30 P.M. for 2 weeks continuously and the
route of administration used was intraperitoneal injections (i.p.). Control animals received an equal amount of
vehicle on the same schedule. HRL-FE at a daily dose
of 4.0 mg/kg body weight was administered via feeding
tube with the same schedule of daily drug administration
to experimental rats in a balanced design.
IV. Experimental Protocol
Twenty-four animals were randomly divided into
two equal groups (twelve animals in each group): (1)
saline injected and (2) haloperidol injected groups.
These animals were injected with haloperidol at a dose
of 3.0 mg/kg body weight (two times a day at 09:00-09:30
A.M. and 05:00-05:30 P.M.) for 2 continuous weeks.
Control animals were injected with saline in volumes of
1.0 mL/kg body weight. On the 6th day of study, locomotor activity in home cages and open field arena were
recorded 15 minutes postinjections of haloperidol and
vehicle in experimental animals. After the completion of
1st week, animals of the two groups were further subdivided into four equal groups (six animals in each group):
(1) saline plus water (2) saline plus HRL-FE (3) haloperidol plus water, and (4) haloperidol plus HRL-FE. On the
15th and last day of experiment 15 min postinjections
activity parameters were recorded again. Food intake
was monitored on the 6th and 15th day of experiment
by providing rats with a weighed amount of food with
proper measurement by subtracting the left over food in
the hopper of the cages. Body weights of the rats were
also monitored on the 6th and 15th day of study. Growth
rate was calculated in terms of percentage of initial body
weight. The animals were then decapitated on the 15th
and last day of study to collect plasma and whole brain
samples. Brain samples were stored at -70°C for the estimation of TRP, 5-HT and 5-hydroxyindoleacetic acid
(5-HIAA) by High Performance Liquid Chromatography
with Electrochemical Detection (HPLC-EC)(16).
V. Behavioral Analysis
(I) Locomotor Activity In Home Cage
The activity boxes used in the present investigation were specifically designed Perspex home cages
(26×26×26 cm) with saw-dust covered floor. Experiment was conducted in a separate quiet room. Locomotor activity was observed in activity boxes for 10 minutes

in terms of numbers of cage crossings in all groups in a
balanced design(16).
(II) Exploratory Activity in an Open Field
The open field apparatus used in the present investigation consisted of a square area 76×76 cm with walls
of 42 cm in height. The floor was divided into 25 equal
squares. To determine the activity, a rat was placed
in the centre square of the open field. Latency to leave
the centre square and numbers of squares crossed with
all four paws were scored for 5 minutes as described
earlier (11,16). The activity of saline injected rats and haloperidol injected and HRL-FE administered rats were
monitored in a balanced design to avoid order effect on
the 6th day between 10:00 and 2:00 h.
VI. Neurochemical Analysis
(I) Brain Dissection
Animals were decapitated and the brains were
removed immediately from the cranial cavity after opening the skull from the frontal cortex rostrally and medulla
oblongata caudally as described by Batool and Haleem(11).
The cerebellum was pinched out by forceps. The brain
dipped in ice cold saline was placed with dorsal side up
in the molded cavity of a brain slicer. Olfactory nucleus
material was discarded and whole brains were stored at
-70°C in order to assay biogenic amines by HPLC-EC.
Plasma samples were also stored at -70°C for biochemical
estimations.
(II) HPLC-EC Determinations of Plasma TRP, Brain TRP
and 5-HT Metabolites
Whole brain samples were extracted and homogenized as described by Haleem(22). Brain TRP, 5-HT
and its metabolites were determined by HPLC-EC as
described by Batool and colleagues(16). A 5µm Shim-Pack
ODS separation column of 4.0 mm internal diameter and
150 mm length was used. Separation was achieved by
mobile phase containing 14% methanol, 0.023% octyl
sodium sulfate and 0.0035% ethylenediaminetetraacetic acid (EDTA) in 0.1 M phosphate buffer of pH 2.9
at an operating pressure 2000-3000 psi on Shimadzu
HPLC pump. Electrochemical detection was achieved on
Shimadzu L-ECD-6A detector at an operating potential
of 0.8 V (glassy carbon electrode vs an Ag/AgCl reference electrode). TRP was determined in a separate run at
an operating potential of 1.0 V.
(VII) Statistical Analysis
In this investigation, the results were presented as a
means ± S.D. Data on locomotor activity in home cages
and open field were analyzed by 2-way ANOVA (repeated
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measure design) followed by Newman-Keuls test. Neurochemical data on the effects of HRL-FE on the synthesis of
brain TRP and 5-HT were analyzed by two-way ANOVA.
Post-hoc comparisons, done with the Newman-Keuls test,
when p < 0.05 were considered significantly different.

in rats repeatedly treated with haloperidol plus orally
supplemented with HRL-FE.
Figure 3 shows the effect of oral supplementation
of HRL-FE (40% preparation; 4.0 mg/kg body weight)
on plasma TRP, brain TRP, 5-HT and 5-HIAA levels of

RESULTS
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Figure 1. Effects of oral administration of (Hippophae rhamnoides
L.) fruit extract (HRL-FE) on Food Intake and Growth Rate in rats
treated with repeated saline and haloperidol. Values are means ± S.D.
(n = 12). Significant differences by Newman-Keuls test: *p<0.01
from respective water treated animals, +p<0.01 from saline treated
plus HRL-FE animals following two-way ANOVA.
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Figure 2. Effects of oral administration of (Hippophae rhamnoides
L.) fruit extract (HRL-FE) on home cage locomotor activity and
open field exploratory activity in rats treated with repeated saline
and haloperidol. Values are means ± S.D. (n = 12). Significant
differences by Newman-Keuls test: *p<0.01 from respective water
treated animals, +p<0.01 from saline treated plus HRL-FE animals
following two-way ANOVA.
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Figure 1 shows the effects of oral supplementation
of HRL-FE (40% preparation; 4.0 mg/kg body weight) on
growth rate (% change in body weight) and cumulative
food intake/24h in rats treated with repeated saline and
haloperidol. No significant effect of HRL-FE was found
in growth rate (F = 2.7; df = 1,20; p>0.05). However,
significant lower food intake (F = 15.6; df = 1,20; p<0.01)
was found in rats treated with repeated haloperidol plus
HRL-FE. Post-hoc analysis showed that oral supplementation of HRL-FE produced significant (p<0.01)
decreases in food intake only in haloperidol treated rats,
while significant increases (p<0.01) were observed in
group of rats treated with repeated haloperidol plus water
administration.
Figure 2 shows the effects of oral supplementation
of HRL-FE (40% preparation; 4.0 mg/kg body weight)
on locomotor activity in familiar environment (in terms
of numbers of cage crossings; akinesia) and exploratory
activity in novel environment (in terms of numbers of
squares crossed in open field arena) in rats treated with
repeated saline and haloperidol. A significant effect of
HRL-FE (F = 21.5; df = 1,20; p<0.01) and haloperidol (F
= 15.6; df=1,20; p<0.01) was observed. Post-hoc analysis showed significant decreases (p<0.01) were found in
group of rats treated with repeated haloperidol. On the
contrary, significant increases (p<0.01) were observed
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Figure 3. Effects of oral administration of (Hippophae rhamnoides
L.) f r uit ext ract (HR L-FE) on plasma TR P, brain TR P, 5-HT
and 5-HIAA concentrations in rats treated with repeated saline
and haloperidol. Values are means ± S.D. (n = 12). Significant
differences by Newman-Keuls test: *p<0.01 from respective water
treated animals, +p<0.01 from saline treated plus HRL-FE animals
following two-way ANOVA.
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repeated saline and haloperidol injected rats. Data on
plasma TRP showed no significant effect of HRL-FE (F
= 1.7; df = 1,20; p>0.05), insignificant effect of drug (F =
2.6; df = 1,20; p<0.05) and no significant interaction (F
= 1.3; df = 1,20; p>0.05) between the HRL-FE and drug.
Data on brain TRP showed significant effect of HRL-FE
(F = 24.8; df = 1,20; p<0.01), significant effect of drug
(F = 24.5; df = 1,20; p<0.01) and significant interaction
(F = 16.5; df = 1,20; p<0.01) between the HRL-FE and
drug. Post-hoc analysis showed that oral supplementation of HRL-FE did not alter the plasma TRP levels but
significant increases (p<0.01) were observed in the levels
of brain TRP.
Data on 5-HT levels showed significant effect of
HRL-FE (F = 24.7; df = 1,20; p<0.01) and significant
effect of drug (F = 12.4; df = 1,20; p<0.01) and significant
interaction (F = 12.5; df = 1,20; p<0.01) was observed
between the HRL-FE and drug. Post-hoc analysis showed
that HRL-FE significantly increased (p<0.01) 5-HT levels
in repeated haloperidol injected rats when compared with
repeated saline plus HRL-FE administered rats. Data on
5-HIAA levels showed a significant effect of HRL-FE (F
= 12.8; df = 1,20; p<0.01) and significant effect of drug
(F = 27.3; df = 1,20; p<0.01) and significant interaction (F = 10.1; df = 1,20; p<0.01) was observed between
the HRL-FE and drug. Post-hoc analysis showed that
HRL-FE significantly increased (p<0.01) 5-HT levels in
repeated haloperidol injected rats when compared with
repeated saline plus HRL-FE administered rats. The
increases in saline plus HRL-FE and repeatedly treated
haloperidol plus HRL-FE were comparable.

DISCUSSION
To our knowledge, potential role of medicinal plant
Sea buckthorn (Hippophae rhamnoides L.) (HRL) as a
dietary nutrient in the modulation of haloperidol-induced
behavioral deficits and increased brain 5-HT metabolism
by HRL fruit extract supplementation to rats reported for
the first time. Reported literature have shown that tryptophan and serotonin are the bioactive ingredients of the
Sea buckthorn(3,5), and they have been known as promising adjuncts in the modulation of antipsychotic therapy
to schizophrenic patients (17,18). Dietary manipulation may
serve as a safer and less invasive means than pharmacologic challenge to provoke serotonergic responsiveness
in schizophrenia studies. Studies have also shown that
repeated neuroleptic therapy in schizophrenic patients
suppresses responsiveness of serotonergic system(19).
Observed food intake decreases (Figure 1) in the present study were explainable by the fact that carbohydrate
rich diet can influence the availability of tryptophan to
the brain and ultimately synthesis of brain 5-HT(20,21).
Thus the synthesis of 5-HT following a tryptophan load
increased in the whole brain(22) and many brain regions
except the striatum(13,23). It is also reported that TRP load

increases 5-HT synthesis in the brain and therefore may
stimulate 5-HT release and functions (19,22). The mechanism by which diet (or TRP) is thought to influence 5HT
synthesis involves the following sequence: the composition of food consumed changes plasma levels of the large
neutral amino acids (LNAA), which affect the rate of
TRP transport into the brain, brain TRP levels and hence
the rate of 5HT synthesis (23). It has been suggested that,
by this mechanism, dietary interventions might influence
a range of behaviors and brain functions linked to serotonergic neurotransmission(22,23).
It is well established that haloperidol (a dopamine
D2 receptor antagonist) prevents hyperactivity induced
by amphetamine decreases spontaneous locomotion and
exploration and elicits a state known as catalepsy (18,24).
The dopamine system traditionally has been considered
crucial to the control of motor activity (19). With respect
to the anatomical site of action a view has developed that
striatum is involved in the control of motor behavior. Striatum, a region of brain involved in the control of motor
activity, is rich in DA nerve terminals (19). Factors that
modulate brain serotonin metabolism have been shown to
produce little effect in this region of the brain(21). Early
studies have shown that the administration of haloperidol for three weeks resulted in an increase in DA receptor
binding. Subsequent studies showed a selective increase
in dopamine D2 receptor binding in rat brain following
prolonged neuroleptic treatment (25,26). The results of the
binding experiments are consistent with behavioral studies on experimental animals. Thus chronic haloperidol
treatment induced DA receptor hypersensitivity in rats
as measured by enhanced hyperactivity and stereotypy
to apomorphine after withdrawal of the neuroleptic (27).
In the present study, 2 weeks of treatment with haloperidol induced a time dependent increase in locomotor and
exploratory activities in groups of rats orally supplemented with HRL-FE. Co-administration of HRL-FE at a dose
of 4.0 mg/kg body weight completely reversed the behavior in a time dependent manner (Figure 2). Observed
effects of repeated administration of haloperidol on
behavioral deficits are explainable in terms of either an
increase in the responsiveness of postsynaptic 5-HT1A
receptors or dopamine D2 receptors or both. The results
are therefore consistent with the notion that a decrease in
the serotonergic influence on the activity of dopaminergic neurons is involved in the induction of EPS while a
normalization of serotonergic influence in rats co-administered with HRL-FE could reverse the behavioral deficits
induced by haloperidol treatment.
The important findings of the present study were that
HRL-FE supplementation not only modified the locomotor activity but also increased brain TRP and 5-HT levels
in the haloperidol injected rats. The levels of free TRP
in plasma have been used as an index in the determination of brain TRP levels under different physiological and
pharmacological conditions (18,22). The increased precursor availability to the brain has a consequence on the
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observed increases in brain 5-HT metabolism(21,22). Our
study suggested that these observed increases in brain
5-HT were associated with the increased availability of its
precursor, TRP. This data can be interpreted as HRL-FE
could have a potential to influence brain serotonin metabolism by altering the activity of rate-limiting enzyme
tryptophan hydroxylase to the substrate. We have also
observed increased level of 5-HIAA in the present study
and number of studies have shown that increases in brain
5-HIAA levels are often taken as a measure of increased
release or utilization of 5-HT in the synapse (16). It is
reported that oral administration of TRP-free amino acid
mixture significantly decreased basal 5-HT and 5-HIAA
levels 100 min after ingestion (65 and 81% of basal value
respectively) and remained at this level for another 140
minutes suggesting that the rate of 5-HT formation varied
directly with the availability of circulating precursor
TRP, the source of which is dietary(28). Findings of the
present study support the idea that oral supplementation
of Sea buckthorn as a nutraceutical in combination with
repeated haloperidol treatment augmented the uptake of
TRP in the brain and consequently increased brain 5-HT
synthesis particularly to the groups of haloperidol treated rats supplemented with HRL-FE (Figure 3). Overall
increases in the locomotor/ exploratory activity and brain
serotonin metabolism suggest the possible role of medicinal plant Sea buckthorn and its fruit in extending therapeutic management of schizophrenia.

CONCLUSIONS
The present study suggests that oral supplementation
of HRL-FE is effective in modifying haloperidol-induced
behavioral deficits. In addition, HRL-FE reversed brain
TRP and 5-HT decreases induced by repeated haloperidol
treatment. It could be suggested that increased precursor availability due to dietary source of HRL-FE in rats
lead to the increased brain 5-HT synthesis. Decreased
food intake and increased brain TRP exhibits an imperative role of nutritional sources of Sea buckthorn rich in
dietary TRP and 5-HT in its fruit extract. In relation to
its medicinal, biochemical and nutritional aspects and
emphasizing role of serotonin in schizophrenia, Sea
buckthorn may be used as a nutritive therapy in psychotic
patients. More issues will be addressed in future studies.
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